Jan 21, 2020 - Is Sanofi (SNY) a great pick from the value investor's perspective right now? Read on to know more.
Jan 16, 2020 - The FDA bestows a Fast Track Designation on Novavax's (NVAX) influenza vaccine candidate NanoFlu for adults aged 65 years and older. Shares rally.
Jan 13, 2020 - Lilly (LLY) offers to buy Dermira for $1.1 billion to add the latter's late-stage candidate for atopic dermatitis/eczema, lebrikizumab.
Jan 11, 2020 - The Super Bowl of healthcare kicked off early for these companies.
Jan 08, 2020 - Here we present three non-cancer therapeutic areas wherein pipeline developments are expected to garner a lot of interest in 2020.
Jan 07, 2020 - Top Stock Reports for JPMorgan, Sanofi & General Electric
Jan 03, 2020 - Amicus (FOLD) progresses with the development of its pipeline. However, the company faces substantial competition.
Dec 14, 2019 - Sanofi has the perfect gift for investors: Investment in its most promising businesses with plans to keep growing the dividend.
Dec 13, 2019 - This week two deals grab headlines in the pharma space. Merck (MRK) offers to buy ArQule for $2.7 billion while Sanofi (SNY) signs a definitive deal to purchase Synthorx for $2.5 billion
Dec 12, 2019 - The Zacks Analyst Blog Highlights: Novartis, AbbVie, Sanofi, Pioneer Natural Resources and Aqua America